Suscripción institucional·Documento·2009·Inglés

[Acute lymphoblastic leukemia: experience in adult patients treated with hyperCVAD and 0195 Protocol, at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Cohort 2003-2007].

Luis Arteaga-Ortíz; Natalie Buitrón-Santiago; Adriana Rosas‐López; Guadalupe Rosas-Arzate; Alicia Armengolt-Jiménez; Álvaro Aguayo; Xavier López‐Karpovitch; Erick Crespo‐Solís

Openalex

Resumen

With HCVAD, we observed worse complete remission, disease-free survival and overall survival rates compared with the original MDACC reports. Chemotherapy related death rates are similar to other early reports, despite prophylactic antibiotic was not used during myelosuppression.

Cómo citar

Luis Arteaga-Ortíz, & Natalie Buitrón-Santiago, & Adriana Rosas‐López, & Guadalupe Rosas-Arzate, & Alicia Armengolt-Jiménez, & Álvaro Aguayo, & Xavier López‐Karpovitch, & Erick Crespo‐Solís (2009). [Acute lymphoblastic leukemia: experience in adult patients treated with hyperCVAD and 0195 Protocol, at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Cohort 2003-2007]..